Rio Rancho Water & Ww Services

PFAS monitoring results for a public water system in New Mexico

NM3509623UCMR 5EPA monitoring data
<MRLHighest PFOA result, ppt
<MRLHighest PFOS result, ppt
0Highest Hazard Index
420Results
PWSID
NM3509623
State
New Mexico
System type
community water system (CWS)
Population served
107,350
City
Rio Rancho
Counties
Bernalillo County, Sandoval County
Primary source water
surface water (purchased)
UCMR 5 sampling
2025-01-14 to 2025-10-07 · 7 entry point(s) · water types: GW
Service-area boundary
authoritative

No PFAS detected highest single result
No PFAS detected worst entry-point average

These are monitoring results collected under EPA's Fifth Unregulated Contaminant Monitoring Rule (UCMR 5) at entry points, where treated water enters the distribution system; they are not tap-water samples. They are not compliance determinations: compliance with EPA's 2024 PFAS limits is judged on running annual averages of compliance monitoring, required from 2029, so a single UCMR 5 result at or above a limit is not a violation. “< MRL” means the compound was not quantified at EPA's minimum reporting level; it does not mean zero.

Water purchased from

Seller results are the seller's own entry-point samples, not measurements of this system's water. This system's own samples (below) may reflect purchased water, its own sources, or both.

Compared with EPA's 2024 values

Highest single resultWorst entry-point average*Limit
PFOA (ppt)<MRL04
PFOS (ppt)<MRL04
Hazard Index001.0†

“<MRL” = every result for the compound was below its reporting limit. * Mean of all samples at each entry point with non-detects = 0 (EPA compliance convention; the Hazard Index also uses non-detects = 0); a screening comparison, not a formal running annual average. † Rescission proposed May 2026. PFOA/PFOS MCL 4 ppt (2024 NPDWR, in effect). PFHxS, PFNA, HFPO-DA (10 ppt each) and the Hazard Index (1.0) are 2024 NPDWR values; EPA proposed rescinding them on 18 May 2026 (comment period closed 20 Jul 2026).

No New Mexico PFAS drinking-water standard in effect or proposed as of 2026-10-17: No New Mexico-specific PFAS drinking-water MCL; NMED implementing federal NPDWR.

Sampling history

Sampled 2025-01-14 to 2025-10-07 · 7 entry point(s) · water types: GW · 16 sampling visits. PFAS in ppt (ng/L).

DateEntry pointEventPFOAPFOSHIOther detections
2025-01-14Well # 15 Treatment Unit - SP096230251 (GW)SE1<4<40lithium 271 µg/L
2025-01-14Well # 3 Treatment Unit (GW)SE1<4<40lithium 85.8 µg/L
2025-01-14Well #10A Treatment Unit (GW)SE1<4<40lithium 393 µg/L
2025-01-14Well #12 Treatment Unit (GW)SE1<4<40lithium 376 µg/L
2025-01-14Well #16 Treatment Unit (GW)SE1<4<40lithium 262 µg/L
2025-07-16Well # 15 Treatment Unit - SP096230251 (GW)SE2<4<40lithium 287 µg/L
2025-07-16Well # 3 Treatment Unit (GW)SE2<4<40lithium 85.8 µg/L
2025-07-16Well #10A Treatment Unit (GW)SE2<4<40lithium 364 µg/L
2025-07-16Well #12 Treatment Unit (GW)SE2<4<40lithium 467 µg/L
2025-07-16Well #16 Treatment Unit (GW)SE2n/an/an/alithium 281 µg/L
2025-07-16Well #6A Treatment Unit (GW)SE1n/an/an/alithium 160 µg/L
2025-08-19Well #17 Treatment Unit (GW)SE1<4<40lithium 82 µg/L
2025-09-16Well #16 Treatment Unit (GW)SE2<4<40none
2025-09-16Well #6A Treatment Unit (GW)SE1<4<40none
2025-10-07Well #17 Treatment Unit (GW)SE2<4<40lithium 78.1 µg/L
2025-10-07Well #6A Treatment Unit (GW)SE2<4<40lithium 118 µg/L

“<4” = not detected at the reporting limit shown; “n/a” = not analyzed in that sample. Highlighted = at or above the 4 ppt MCL. HI computed per sample with non-detects as 0. Other detections lists every other quantified compound (lithium in µg/L).

All results by entry point

420 results. Each column is one sampling visit (date and UCMR 5 sample event). A number is a measured concentration; “< 4” = below the minimum reporting level shown; “–” = not analyzed in that visit. PFAS in ppt (ng/L); lithium in µg/L.

Well # 15 Treatment Unit - SP096230251 facility 93025 · sample point SP09623051 · groundwater

CompoundMRL2025-01-14
SE1
2025-07-16
SE2
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L271287

Well # 3 Treatment Unit facility 93028 · sample point SP096230281 · groundwater

CompoundMRL2025-01-14
SE1
2025-07-16
SE2
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L85.885.8

Well #10A Treatment Unit facility 93041 · sample point SP096230411 · groundwater

CompoundMRL2025-01-14
SE1
2025-07-16
SE2
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L393364

Well #12 Treatment Unit facility 93030 · sample point SP096230301 · groundwater

CompoundMRL2025-01-14
SE1
2025-07-16
SE2
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L376467

Well #16 Treatment Unit facility 93031 · sample point SP096230311 · groundwater

CompoundMRL2025-01-14
SE1
2025-07-16
SE2
2025-09-16
SE2
11Cl-PF3OUdS5 ppt< 5–< 5
4:2 FTS3 ppt< 3–< 3
6:2 FTS5 ppt< 5–< 5
8:2 FTS5 ppt< 5–< 5
9Cl-PF3ONS2 ppt< 2–< 2
ADONA3 ppt< 3–< 3
HFPO-DA5 ppt< 5–< 5
NEtFOSAA5 ppt< 5< 5–
NFDHA20 ppt< 20–< 20
NMeFOSAA6 ppt< 6< 6–
PFBA5 ppt< 5–< 5
PFBS3 ppt< 3–< 3
PFDA3 ppt< 3–< 3
PFDoA3 ppt< 3–< 3
PFEESA3 ppt< 3–< 3
PFHpA3 ppt< 3–< 3
PFHpS3 ppt< 3–< 3
PFHxA3 ppt< 3–< 3
PFHxS3 ppt< 3–< 3
PFMBA3 ppt< 3–< 3
PFMPA4 ppt< 4–< 4
PFNA4 ppt< 4–< 4
PFOA4 ppt< 4–< 4
PFOS4 ppt< 4–< 4
PFPeA3 ppt< 3–< 3
PFPeS4 ppt< 4–< 4
PFTA8 ppt< 8< 8–
PFTrDA7 ppt< 7< 7–
PFUnA2 ppt< 2–< 2
lithium9 µg/L262281–

Well #17 Treatment Unit facility 93035 · sample point SP096230351 · groundwater

CompoundMRL2025-08-19
SE1
2025-10-07
SE2
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L8278.1

Well #6A Treatment Unit facility 93024 · sample point SP096230241 · groundwater

CompoundMRL2025-07-16
SE1
2025-09-16
SE1
2025-10-07
SE2
11Cl-PF3OUdS5 ppt–< 5< 5
4:2 FTS3 ppt–< 3< 3
6:2 FTS5 ppt–< 5< 5
8:2 FTS5 ppt–< 5< 5
9Cl-PF3ONS2 ppt–< 2< 2
ADONA3 ppt–< 3< 3
HFPO-DA5 ppt–< 5< 5
NEtFOSAA5 ppt< 5–< 5
NFDHA20 ppt–< 20< 20
NMeFOSAA6 ppt< 6–< 6
PFBA5 ppt–< 5< 5
PFBS3 ppt–< 3< 3
PFDA3 ppt–< 3< 3
PFDoA3 ppt–< 3< 3
PFEESA3 ppt–< 3< 3
PFHpA3 ppt–< 3< 3
PFHpS3 ppt–< 3< 3
PFHxA3 ppt–< 3< 3
PFHxS3 ppt–< 3< 3
PFMBA3 ppt–< 3< 3
PFMPA4 ppt–< 4< 4
PFNA4 ppt–< 4< 4
PFOA4 ppt–< 4< 4
PFOS4 ppt–< 4< 4
PFPeA3 ppt–< 3< 3
PFPeS4 ppt–< 4< 4
PFTA8 ppt< 8–< 8
PFTrDA7 ppt< 7–< 7
PFUnA2 ppt–< 2< 2
lithium9 µg/L160–118

Statistics by compound

CompoundResultsDetectedHighest (date)Mean boundsKM medianP75P90P95
lithium14100%467
2025-07-16
236.48–236.48262364393467

Never detected (29): 11Cl-PF3OUdS, 4:2 FTS, 6:2 FTS, 8:2 FTS, 9Cl-PF3ONS, ADONA, HFPO-DA, NEtFOSAA, NFDHA, NMeFOSAA, PFBA, PFBS, PFDA, PFDoA, PFEESA, PFHpA, PFHpS, PFHxA, PFHxS, PFMBA, PFMPA, PFNA, PFOA, PFOS, PFPeA, PFPeS, PFTA, PFTrDA, PFUnA.

Left-censored Kaplan–Meier statistics (Helsel 2005; Helsel & Lee 2006, NADA for R). Units: ppt; lithium µg/L. Each compound has one reporting limit, so the Kaplan–Meier mean equals the upper mean bound (non-detects at the MRL); the lower bound sets non-detects to 0. “<MRL” = the percentile falls below the reporting limit and cannot be estimated. These describe this system's UCMR 5 samples, not population estimates.

Sources

  • EPA UCMR 5 occurrence data text files (UCMR5_All.txt; samples 2023-01-09 to 2026-03-18; data summary dated Jul 2026)
  • EPA SDWIS via ECHO SDWA downloads, quarter 2026Q3
  • EPA Public Water System Service Areas v3 (Mar 2026)
  • US Census Bureau cartographic boundary counties 1:500k, 2024
  • EPA/USGS NHDPlus V2 (medium resolution) flowlines, Strahler order 2+

Data build 2a8dc22a55ff · 2026-10-18T04:05Z · UCMR 5 release Jul2026 · SDWIS 2026Q3. Data and methods.